Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

WILD 5 Wellness: A 30-Day Intervention

24. april 2018 oppdatert av: Beloit College
The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition in Beloit College students. This program is called "WILD 5 Wellness: A 30-Day Intervention". Results for this study will be quantified through the use of standardized self-report questionnaires administered prior to and after students complete the WILD 5 program (Group 1) or 30 days of inactive participation (Group 2), and again approximately 30 days later when the initially inactive group (Group 2) will have just completed their active participation in the WILD 5 program and the first WILD 5 group (Group 1) will be approximately 30 days out from completion of their WILD 5 active portion. Data will be collected to evaluate participants' adherence and response to each element of WILD 5, a 5-pronged 30-day wellness intervention. It is expected that this 30-day integrated, prescriptive, and trackable program will be found to be an efficacious wellness intervention for Beloit College students as compared to the control (inactive) group of students not participating in the Active program.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

88

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Wisconsin
      • Beloit, Wisconsin, Forente stater, 53511
        • Beloit College

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Beloit College student enrolled in one or more of the following Spring 2017 academic courses:
  • Anthropology 201 01 "Research Designs: Sophomore Seminar in Anthropology"
  • Health and Society 240 B1 "Sophomore Seminar in Health and Society"
  • Spanish 218 "Health and Culture in the Spanish-Speaking World"
  • Biology 373 "Neuroscience Research"
  • Biology 215 "Emerging Diseases"

Exclusion Criteria:

  • Individuals who are <18 years old
  • Individuals who are acutely suicidal and/or actively psychotic
  • Individuals who are pregnant or plan to get pregnant during the next 60 days, or who are not registered in one of the courses listed above.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Annen: Group 1
Group 1 will be active in the WILD 5 Wellness program the first 30 days and inactive the 2nd 30 days.
Participants will be asked to voluntarily engage in integrated, prescriptive, and trackable wellness interventions combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition.
Annen: Group 2
Group 2 will be inactive in the WILD 5 Wellness program the first 30 days and active the 2nd 30 days.
Participants will be asked to voluntarily engage in integrated, prescriptive, and trackable wellness interventions combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition.

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
WILD 5 Wellness Scale (W5WS), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
WILD 5 Wellness Elements (W5WE), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
WILD 5 Wellness Effort Scale (W5WES), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
WHO (World Health Organization) 5 Well-Being Index (1998 version), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Social Connectedness Scale (SCS), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Sleep Condition Indicator (SCI), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Sheehan Disability Scale (SDS), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Patient Health Questionnaire (PHQ-9), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Mindful Attention Awareness Scale (MAAS), Day to Day Experiences, Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
MIND ( Mediterranean-DASH Intervention for Neurodegenerative Delay)Diet, Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Generalized Anxiety Disorder (GAD-7), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Eating and Appraisal Due to Emotions and Stress Questionnaire (EADES), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Cognitive and Physical Functioning Questionnaire (CPFQ), Assessing Change
Tidsramme: Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Post Program Participant Questionnaire
Tidsramme: The end of the 30 day active participation in WILD 5 Wellness for each group (1 and 2)
The end of the 30 day active participation in WILD 5 Wellness for each group (1 and 2)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

6. februar 2017

Primær fullføring (Faktiske)

18. april 2017

Studiet fullført (Faktiske)

5. desember 2017

Datoer for studieregistrering

Først innsendt

17. januar 2017

Først innsendt som oppfylte QC-kriteriene

19. januar 2017

Først lagt ut (Anslag)

23. januar 2017

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

26. april 2018

Siste oppdatering sendt inn som oppfylte QC-kriteriene

24. april 2018

Sist bekreftet

1. april 2018

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 302

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere